CHEN ISAN 4
4 · Mirati Therapeutics, Inc. · Filed May 13, 2020
Insider Transaction Report
Form 4
CHEN ISAN
Chief Medical & Dev't Officer
Transactions
- Exercise/Conversion
Common Stock
2020-05-11$24.99/sh+33,334$833,017→ 72,735 total - Sale
Common Stock
2020-05-11$105.00/sh−33,334$3,500,070→ 39,401 total - Exercise/Conversion
Stock Options
2020-05-11−33,334→ 23,420 totalExercise: $24.99Exp: 2026-01-21→ Common Stock (33,334 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 2, 2019.
- [F2]This transaction was executed in multiple trades at prices ranging from $105.00 to $105.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.